Nautilus Biotechnology, Inc.
NAUT- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001808805
No open-market purchases or sales by Nautilus Biotechnology, Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $93.7M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Nautilus Biotechnology, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 68 | 4 | 68 | +4 |
| Shares | 57.9M | 17.5K | 58.3M | +414.1K (+0.7%) |
| Value | $48.9M | $14.8K | $113.7M | +$64.8M (+132.5%) |
4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sentinel Trust Co Lba | 750,000 | $1.46M | 0.14% |
| Marshall Wace, LLP | 117,059 | $228.3K | 0.00% |
| Omers Administration Corp | 104,785 | $204.3K | 0.00% |
| Point72 Asset Management, L.P. | 60,833 | $118.6K | 0.00% |
| Susquehanna International Group, LLP | 42,916 | $83.7K | 0.00% |
| Lighthouse Investment Partners, LLC | 40,200 | $78.4K | 0.00% |
| Captrust Financial Advisors | 34,011 | $66.3K | 0.00% |
| Hudson Bay Capital Management LP | 19,062 | $37.2K | 0.00% |
| Garde Capital, Inc. | 18,000 | $35.1K | 0.00% |
| Two Sigma Securities, LLC | 16,239 | $31.7K | 0.00% |
| Group One Trading, L.P. | 3,880 | $7.57K | 0.00% |
Sold out (7)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 301,012 | $254.3K |
| Citadel Advisors LLC | 254,161 | $214.7K |
| JPMorgan Chase & Co | 2,121 | $1.79K |
| Aventura Private Wealth, LLC | 350 | $296 |
| SRS Capital Advisors, Inc. | 148 | $125 |
| True Wealth Design, LLC | 17 | $15 |
| Cloud Capital Management, LLC | 49 | $0 |
Not filed for Q4 2025 yet (4)
Institutions that held Nautilus Biotechnology, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Point72 Asia (Singapore) Pte. Ltd. | 16,271 | $13.7K |
| Point72 (DIFC) Ltd | 789 | $667 |
| Guerra Advisors Inc | 400 | $338 |
| Cubist Systematic Strategies, LLC | 1 | $1 |